Latest Security News

Tivan Limited has initiated a comprehensive program of works at its recently acquired Molyhil Tungsten-Molybdenum Project, setting the stage for drilling and resource expansion in early 2026.

Canyon Resources confirms steady progress at its Minim Martap bauxite project in Cameroon, with mining set to start in early 2026 and first shipments expected by mid-year, supported by secured financing and key equipment deliveries.

Macquarie Group Limited has announced a quarterly distribution of AUD 1.5799 per security on its perpetual capital notes, reflecting a steady income stream with partial franking. The payment is scheduled for December 12, 2025.

Embark Early Education has announced an off-market takeover bid for Mayfield Childcare, valuing the company at nearly $38 million and offering shareholders a premium over recent prices. The move aims to create a larger childcare group with enhanced resources and educational outcomes.

Macquarie Group Limited announces a quarterly dividend of AUD 1.4003 per security on its CAP NOTE 3-BBSW+2.90% PERP NON-CUM RED T-09-27, with a partly franked distribution and a payment date set for December 18, 2025.

Macquarie Group Limited has announced a quarterly distribution of AUD 1.6773 per security for its capital note, payable on December 10, 2025, reflecting a stable income stream for investors.

Light & Wonder, Inc. is set to extend its substantial share repurchase program to include its ASX-listed CHESS Depositary Interests starting November 7, 2025, coinciding with its planned Nasdaq delisting.

RocketDNA has landed a significant contract with Anglo American’s Kumba Iron Ore to supply and integrate seven autonomous drone systems at the Sishen Mine, marking a key step in expanding AI-driven mining technology in Africa.

G11 Resources has identified a promising new copper and gold drill target at Sedgwick Bluff, Tasmania, adjacent to the historic Mt Lyell mine. The discovery, based on advanced geophysical modelling, sets the stage for imminent drilling pending environmental and regulatory approvals.

AVITA Medical reported an 18% revenue increase in Q3 2025 driven by new product launches and deeper market penetration, while continuing to face net losses and credit covenant challenges. The company also announced a CEO departure and interim leadership appointment.

AVITA Medical reported a 13% revenue decline in Q3 2025 but improved cash efficiency and secured Medicare payment confirmations for RECELL®, positioning for growth in 2026.

AVITA Medical reported a 13% drop in Q3 commercial revenue to $17.1 million but improved its net loss and secured CE Mark approval for RECELL GO in Europe, signaling strategic shifts ahead.